Spotlight on Hand-Foot Syndrome
- 期刊名称Natural Products Chemistry & Research
- 作者Rasool Hassan, Bassam Abdul
- 卷第2卷
- 期第3期
- 印刷ISSN2329-6836
- 文件大小232.54KB
- 发表时间2014
- DOI10.4172/2329-6836.1000e107
Ezetimibe + low-dose atorvastatin vs high-dose atorvastatin2007
One year persistence of atorvastatin and amlodipine fixed dose combination versus atorvastatin therapySimonyi, G.; Tamás, F. · Atherosclerosis · 2016
Safety Outcomes of Atorvastatin 80 mg Versus Atorvastatin 40 mg in a Veteran PopulationJacobs, Devon; Wassell, Katelyn; Guidry, Tommie Jo; Sullivan, Joshua · Annals of Pharmacotherapy · 2019
Cardiovascular event rates in atorvastatin patients versus patients switching from atorvastatin to simvastatinJacobson, Terry A.; Wertz, Debra A.; Kuznik, Andreas; Cziraky, Mark · Current Medical Research and Opinion · 2013
Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial — FAT)Malik, J · Cardiovascular Research · 2001
Development and validation of a high-performance liquid chromatography tandem mass spectrometry assay for atorvastatin, ortho-hydroxy atorvastatin, and para-hydroxy atorvastatin in human, dog, and rat plasmaWilliam W Bullen; Ronald A Miller; Roger N Hayes · 1999
Rapid, Selective, and Rugged Method Development and Validation of Atorvastatin and its Active Metabolites, <i>o</i> -Hydroxy Atorvastatin and <i>p</i> -Hydroxy Atorvastatin, in Stabilized Plasma Using Liquid Chromatography Coupled with Tandem Mass SpectrometryBayya, Venkanna; Makula, Ajitha; Sanka, Krishna; Borra, Naga Sandhya; Chaganty, Sreedhara · Journal of Liquid Chromatography & Related Technologies · 2015
Cumulative clinical trial data on atorvastatin for reducing cardiovascular events: the clinical impact of atorvastatinBybee, Kevin A.; Lee, John H.; O'Keefe, James H. · Current Medical Research and Opinion · 2008
NevirapineKarunanithi, Sellam; Singh, Harmandeep; Sharma, Punit; Gupta, Deepak Kumar; Bal, Chandrasekhar · Reactions Weekly · 2013
MinocyclineKarunanithi, Sellam; Singh, Harmandeep; Sharma, Punit; Gupta, Deepak Kumar; Bal, Chandrasekhar · Reactions Weekly · 2013
Octocog-αKarunanithi, Sellam; Singh, Harmandeep; Sharma, Punit; Gupta, Deepak Kumar; Bal, Chandrasekhar · Reactions Weekly · 2013
Sugammadex/vecuronium bromide interactionKarunanithi, Sellam; Singh, Harmandeep; Sharma, Punit; Gupta, Deepak Kumar; Bal, Chandrasekhar · Reactions Weekly · 2013
ErythromycinKarunanithi, Sellam; Singh, Harmandeep; Sharma, Punit; Gupta, Deepak Kumar; Bal, Chandrasekhar · Reactions Weekly · 2013
TenofovirKarunanithi, Sellam; Singh, Harmandeep; Sharma, Punit; Gupta, Deepak Kumar; Bal, Chandrasekhar · Reactions Weekly · 2013
Amiodarone/methotrexateKarunanithi, Sellam; Singh, Harmandeep; Sharma, Punit; Gupta, Deepak Kumar; Bal, Chandrasekhar · Reactions Weekly · 2013
Glatiramer acetateKarunanithi, Sellam; Singh, Harmandeep; Sharma, Punit; Gupta, Deepak Kumar; Bal, Chandrasekhar · Reactions Weekly · 2013
Biperiden/trihexyphenidylReactions Weekly · 1995
NitrendipineReactions Weekly · 2003
ScopolamineReactions Weekly · 2007
ScopolamineReactions Weekly · 2012
ScopolamineReactions Weekly · 2009
Centella asiaticaReactions Weekly · 2011
Daunorubicin/mitoxantroneReactions Weekly · 2007
AnthracyclinesReactions Weekly · 1991